Issue 37, 2021

Development and application of ultrasound contrast agents in biomedicine

Abstract

With the rapid development of molecular imaging, ultrasound (US) medicine has evolved from traditional imaging diagnosis to integrated diagnosis and treatment at the molecular level. Ultrasound contrast agents (UCAs) play a crucial role in the integration of US diagnosis and treatment. As the micro-bubbles (MBs) in UCAs can enhance the cavitation effect and promote the biological effect of US, UCAs have also been studied in the fields of US thrombolysis, mediated gene transfer, drug delivery, and high intensity focused US. The application range of UCAs is expanding, and the value of their applications is improving. This paper reviews the development and application of UCAs in biomedicine in recent years, and the existing problems and prospects are pointed out.

Graphical abstract: Development and application of ultrasound contrast agents in biomedicine

Article information

Article type
Review Article
Submitted
15 Apr 2021
Accepted
03 Aug 2021
First published
06 Aug 2021

J. Mater. Chem. B, 2021,9, 7633-7661

Development and application of ultrasound contrast agents in biomedicine

Y. Wang, H. Cong, S. Wang, B. Yu and Y. Shen, J. Mater. Chem. B, 2021, 9, 7633 DOI: 10.1039/D1TB00850A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements